» Articles » PMID: 21958343

A Risk-analysis Approach to the Evaluation of Analytical Quality

Overview
Specialties Biochemistry
Pathology
Date 2011 Oct 1
PMID 21958343
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Setting specifications for analytical quality is always difficult. The risk-management approach might be a way to do so. In this approach, the definition of the required analytical quality is based on the evaluation of patient risk. Risk derives from the probability of error and from the damage that such an error might cause.

Methods: Eight Italian laboratories took part in this experiment. Measurements of glucose and total calcium were taken as examples. Analytical quality was evaluated using a specific ring trial with a frozen serum pool and by means of internal quality-control data. The total allowable error was defined according to biological variation specifications. The probability of error was extracted from the imprecision and comparative bias data of each laboratory. The damage caused by a wrong result was evaluated using the absolute probability judgment approach.

Results: According to the iso-risk plots (standardized hyperboles on a graph where the x-axis represents damage and the y-axis represents probability) for glucose, all the laboratories were working with an analytical quality that guaranteed low risk for patients. On the contrary, for total calcium none of the laboratories exhibited sufficient quality to guarantee low risk for patients, the presence of bias being the most relevant problem.

Conclusions: The results seem to demonstrate the applicability of the risk approach to the analytical phase, indicating a new possible way to define analytical quality targets.

Citing Articles

Analytical performance assessment and improvement by means of the Failure mode and effect analysis (FMEA).

Guinon L, Soler A, Gisell Diaz M, Fernandez R, Rico N, Bedini J Biochem Med (Zagreb). 2020; 30(2):020703.

PMID: 32292281 PMC: 7137999. DOI: 10.11613/BM.2020.020703.


The role of the pathology department in the preanalytical phase of molecular analyses.

Susman S, Berindan-Neagoe I, Petrushev B, Pirlog R, Florian I, Mihu C Cancer Manag Res. 2018; 10:745-753.

PMID: 29695931 PMC: 5903845. DOI: 10.2147/CMAR.S150851.


Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research.

OBryant S, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S Alzheimers Dement. 2014; 11(5):549-60.

PMID: 25282381 PMC: 4414664. DOI: 10.1016/j.jalz.2014.08.099.